Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences [Accessibility Statement] Skip NavigationNEW YORK, Feb. 19, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation for three major clinical conferences this quarter. These events are pivotal to the company's expansion, providing U.S. clinicians dir ...

Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping [Accessibility Statement] Skip NavigationFoundational Patent Strengthens AI Moat Across Multimodal Data Standardization, Disease Stratification and Gene MappingSACRAMENTO, Calif., Feb. 19, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI), an AI-driven biotechnology company advancing precision therapeutics in central nervous system (CNS) disorders and oncology, as well as solutions for ...

Core Viewpoint - IceCure Medical Ltd. has announced that Thomas Hospital in Alabama has installed the ProSense® system, making it the first hospital in the state to offer breast cancer cryoablation procedures, which are set to begin in the coming weeks [1]. Group 1: Company Developments - IceCure Medical specializes in minimally-invasive cryoablation technology aimed at destroying tumors through freezing, providing an alternative to surgical tumor removal [1]. - The ProSense® Cryoablation System is the first medical device to receive FDA marketing authorization for the local treatment of low-risk breast cancer in women aged 70 and above, including those unsuitable for surgical options [1]. - The installation of ProSense® at Thomas Hospital was funded by the Thomas Hospital Foundation, which aims to support access to advanced medical technology [1]. Group 2: Market Impact - The installation follows increased interest in ProSense® after its FDA clearance in October 2025 for treating low-risk breast cancer, indicating a potential rise in installations across other facilities [1]. - IceCure's Vice President of Sales noted that the hospital network's patient volume could lead to a significant number of eligible women benefiting from the ProSense® system as a minimally invasive treatment option [1]. Group 3: Technology Overview - ProSense® utilizes liquid nitrogen to create large lethal zones for effective tumor destruction in both benign and cancerous lesions, enhancing patient recovery and reducing surgical risks [1]. - The system's design allows for fast and convenient office-based procedures, making it a valuable addition to breast cancer treatment options [1].

Core Insights - Travelzoo reported a consolidated revenue of $22.5 million for Q4 2025, representing a 9% increase year-over-year from $20.7 million [1] - The company experienced a net loss of $19,000, or $0.00 per share, compared to a profit of $3.2 million, or $0.26 per share, in the prior-year period [1] - Non-GAAP operating profit was $0.9 million, excluding certain expenses, while GAAP operating income was $554,000 [1] Financial Performance - Revenue for Q4 2025 was $22.5 million, up 9% from $20.7 million year-over-year; in constant currencies, revenue was $22.1 million, up 7% [1] - North America segment revenue increased 6% year-over-year to $14.8 million, while Europe segment revenue rose 16% to $6.3 million [1] - Operating profit for North America was $1.5 million (10% of revenue), down from $4.6 million (33% of revenue) in the prior-year period [1] - Europe segment reported an operating loss of $1 million (16% of revenue), compared to an operating profit of $159,000 (3% of revenue) in the prior-year period [1] Membership and Marketing - The company invested significantly in acquiring new Club Members, leading to increased marketing costs that were expensed immediately [1] - Membership fees revenue is recognized ratably over a 12-month subscription period, impacting EPS negatively [1] - Travelzoo aims to leverage its global reach and relationships with travel suppliers to negotiate more offers for Club Members [1] Cash Flow and Balance Sheet - Cash flow from operations was $1.5 million, with cash, cash equivalents, and restricted cash totaling $10.8 million as of December 31, 2025 [1] - Deferred revenue increased due to the recognition of membership fees over the subscription period [1] Future Outlook - The company expects continued revenue growth in Q1 2026 and subsequent quarters as more Legacy Members transition to Club Members [1] - Profitability is anticipated to increase over time as recurring membership fees are recognized [1]

Core Viewpoint - American Public Education, Inc. (APEI) is scheduled to hold a conference call on March 12, 2026, to discuss its financial results for the fourth quarter and full year ended December 31, 2025 [1]. Company Overview - APEI provides online and campus-based postsecondary education to approximately 109,000 students [1]. - The company operates through its institutions: American Public University System (APUS), Rasmussen University, and Hondros College of Nursing [1]. - APUS serves around 88,700 adult learners globally and is recognized as a leading educator for active-duty military and veteran students [1]. - Rasmussen University, with a history of 125 years, serves approximately 15,900 students across 18 campuses in five states and online [1]. - Hondros College of Nursing focuses on pre-licensure nursing education and serves about 4,000 students, being the largest educator of PN (LPN) nurses in Ohio [1]. Financial Call Details - The conference call will take place at 5:00 PM Eastern Time, with a toll-free dial-in option available [1]. - A replay of the conference call will be accessible until March 26, 2026 [1].

Core Insights - MDA Space has launched 49North, a subsidiary focused on delivering multi-domain C4ISR and mission-critical capabilities for Canada's national defense [1] - Joe Armstrong has been appointed as President of 49North, bringing over 25 years of experience in the defense, aerospace, and technology sectors [1] - The establishment of 49North aims to enhance Canada's domestic industrial capacity and investment in defense capabilities [1] Company Overview - MDA Space is a leader in the global defense and space industry, with over 55 years of experience and more than 450 missions [2] - The company specializes in communications satellites, Earth and space observation, and space exploration [2] - MDA Space employs a team of over 3,800 experts dedicated to transforming customer visions into achievable missions [2] Strategic Focus - 49North will focus on integrating advanced sensing technologies, autonomous systems, and secure digital mission systems across land, air, maritime, and joint domains [1] - The subsidiary aims to provide operational readiness and effectiveness in complex environments, enhancing situational awareness for Canadian and allied forces [1] - MDA Space's commitment to sovereign defense capabilities is reinforced through the establishment of 49North [1]

Core Insights - Markel has announced a collaboration with Upfort to enhance cyber protection for eligible U.S. cyber policyholders, providing tools to mitigate cyberattack risks [1][3] Group 1: Collaboration Details - The Upfort Shield platform offers AI-powered, automated protection against common cyber threats, available to Markel's eligible cyber policyholders [2] - The collaboration aims to strengthen Markel's comprehensive approach to cyber insurance, ensuring support for clients before, during, and after cyber incidents [3] Group 2: Strategic Goals - This partnership aligns with Markel's long-term strategy to deliver innovative insurance solutions tailored for middle-market businesses, enhancing risk prevention capabilities [3] - By utilizing Upfort's platform, Markel aims to reduce claim frequency and gain actionable intelligence for data-driven underwriting [4] Group 3: Upfort's Capabilities - Upfort provides a multi-layer cyber defense solution, including advanced email protection, continuous monitoring, and employee training to bolster business resilience [3][6] - The platform is designed to close the protection gap through AI-powered defense and intelligent automation, leveraging proprietary threat intelligence [6]

Core Insights - Ease of use has become the primary factor for real estate agents when selecting new technology, surpassing cost and time savings [2][3] - Nearly half of the agents now use AI tools daily, indicating a significant shift in the industry's workflow dynamics [4][5] Technology Adoption - Agents typically manage their workflows across two to four different tools weekly, despite the availability of innovative solutions that could streamline their processes [2] - AI tools like ChatGPT, Gemini, and Claude are increasingly integrated into agents' daily routines, with team agents using them more frequently than independent agents [4][5] Cognitive Load and Workflow Management - The fragmentation of workflows across multiple platforms leads to a drain on mental energy, which could otherwise be directed towards client service [3] - Tools that simplify tasks and reduce cognitive load are essential for agents to focus on building relationships and providing strategic guidance [3][6] Zillow Pro Platform - Zillow Pro is set to launch as a unified platform that integrates essential tools for agents, enhancing their efficiency and effectiveness [7][8] - The platform aims to reduce the mental load associated with managing disparate systems, allowing agents to concentrate on client service and transaction closure [8] Financial Literacy and Client Engagement - Many agents report that new clients often overestimate their home affordability, highlighting a gap in financial literacy that agents need to address [8][14] - Zillow Home Loans' verified pre-approval and the Buyability tool are designed to empower consumers by providing clearer insights into their financial capabilities [9][14] Relationship Building - Relationships remain the most significant driver of business for agents, with most new leads coming from their existing network [14] - Agents utilize comparable home data to set listing prices, with a majority relying on price history and market statistics to inform their decisions [14]

Core Viewpoint - Omnicom is set to hold an Investor Day on March 12, 2026, showcasing its strategic direction and growth initiatives [1] Group 1: Investor Day Details - The Investor Day will begin at 9:00 a.m. Eastern Time and is expected to conclude around 12:30 p.m. Eastern Time [1] - Presentations will be delivered by executive management and operational leaders, with a live webcast available on Omnicom's investor relations website [1] Group 2: Company Overview - Omnicom is recognized as the world's leading marketing and sales company, focusing on intelligent growth for the future [1] - The company utilizes its Connected Capabilities, which integrate its agency brands, talent, and expertise across various sectors including media, commerce, and advertising to meet client growth priorities [1]

Core Insights - Bausch Health's OraPharma celebrates the 25th anniversary of ARESTIN® (minocycline HCl) Microspheres, the only FDA-approved locally applied antibiotic for periodontal disease treatment [1] - ARESTIN is used in conjunction with scaling and root planing (SRP) to reduce pocket depth in adult patients with periodontitis, supported by over two decades of clinical experience [1] - The company emphasizes its commitment to periodontal care and innovation, aiming to improve access to treatment options in areas with unmet needs, including recent expansions into Canada and Puerto Rico [1] Product Overview - ARESTIN® (minocycline HCl) Microspheres, 1 mg, is specifically designed for adult periodontitis treatment and is part of a comprehensive oral health program [1] - The product delivers antibiotic therapy directly into the periodontal pocket using microspheres that gradually release the antibiotic [1] Market Context - Periodontal disease affects over one billion people globally, highlighting the significant need for effective treatment options [1] - The company aims to deepen collaboration with the dental community to enhance non-surgical periodontal treatment for appropriate patients [1]